Here's Why VCYT Stock Could be a Great Addition to Your Portfolio Now [Yahoo! Finance]
Veracyte, Inc. (VCYT)
Last veracyte, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.veracyte.com/investor-relations
Company Research
Source: Yahoo! Finance
The record volume growth of the Decipher Prostrate test instills optimism. Additionally, strong financial stability bodes well. Meanwhile, headwinds such as macroeconomic issues are worrisome. In the past year, this Zacks Rank #1 (Strong Buy) company's shares have outperformed both the industry and the S&P 500. The stock has risen 44% compared with the industry's 4.8% growth and the S&P 500 composite's 27.3% increase. The renowned diagnostics company has a market capitalization of $3.17 billion. The company's earnings are likely to surge 137.2% in 2024 compared with 15.5% growth of the industry. In the trailing four quarters, VCYT delivered an average earnings surprise of 520.5%. Tailwinds for VCYT Stock Afirma Continues to Outperform : Veracyte's comprehensive Afirma solution consists of the Afirma GSC (Genomic Sequencing Classifier) and the Afirma Xpression Atlas. An estimated 600,000 people in the United States undergo this procedure each year. Afirma GSC testing is recom
Show less
Read more
Impact Snapshot
Event Time:
VCYT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VCYT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VCYT alerts
High impacting Veracyte, Inc. news events
Weekly update
A roundup of the hottest topics
VCYT
News
- Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks? [Yahoo! Finance]Yahoo! Finance
- 3 Medical Instruments Industry Stocks to Buy on the GenAI Wave [Yahoo! Finance]Yahoo! Finance
- Those who invested in Veracyte (NASDAQ:VCYT) a year ago are up 68% [Yahoo! Finance]Yahoo! Finance
- Veracyte's Decipher Prostate Test Is Now the Only Gene Expression Test Recommended in NCCN® Prostate Cancer Guidelines [Yahoo! Finance]Yahoo! Finance
- Veracyte’s Decipher Prostate Test Is Now the Only Gene Expression Test Recommended in NCCN® Prostate Cancer GuidelinesBusiness Wire
VCYT
Earnings
- 11/6/24 - Beat
VCYT
Sec Filings
- 1/2/25 - Form 144
- 12/17/24 - Form 4
- 12/13/24 - Form 144
- VCYT's page on the SEC website